Sign Out
The following adverse reactions have been reported spontaneously during post-marketing use. A precise frequency can not be estimated form available data (not known).
Gastrointestinal disorders: Gastro-intestinal disturbances have been observed, e.g. abdominal pain, diarrhea, nausea, vomiting, and dysphagia (difficulty swallowing). Oesophageal lesion may occur when not applied as advised (see Dosage & Administration).
Skin and subcutaneous tissue disorders: Cutaneous (skin) effects have been observed, e.g. rash, pruritus (itchiness), urticaria (hives), and erythema (reddening of the skin).
Immune system disorders: Hypersensitivity reactions may occur.
View ADR Reporting Link
Continue with Google